{
Pfizer Inc.

Companies

}
Very Negative
Negative
Neutral
Positive
Very Positive
2025-04-012025-04-011111100
Download SVG
Download PNG
Download CSV
Somewhat Relevant
Moderately Relevant
Very Relevant
Highly Relevant
2025-04-012025-04-011111100
Download SVG
Download PNG
Download CSV

rising allergy prevalence drives demand for epinephrine auto-injectors and innovations

A global strategy consulting firm is poised to enhance competitive advantages in the healthcare sector through innovative technological solutions and advanced analytics. The regenerative medicine market is projected to grow from USD 20.09 billion in 2024 to USD 139.70 billion by 2034, while the pharmaceutical market is expected to nearly double from USD 1,573.20 billion in 2023 to USD 3,033.21 billion by 2034. Recent FDA approvals, including a new epinephrine injection, highlight ongoing advancements in medical treatments.
GlobeNewswire News Room
United States Dollar Teva Pharmaceuticals Sanofi SA Abbott Laboratories Pfizer Inc. CHN USA Kaleo Pilanca Show more
Healthcare, Market Report
16:30 03.12.2024

Top Health Care Stocks to Consider for Investment in 2025

Amgen's MariTide obesity drug showed mid-stage trial results in line with competitors, while Stryker's Mako robotic product and outpatient focus position it as a strong investment. Pfizer's potential divestment of its hospital drugs business could enhance its core growth, and Boston Scientific's promising pipeline supports its long-term outlook. CFRA maintains "buy" ratings for these companies, with specific price targets reflecting their growth potential.
money.usnews.com
Johnson & Johnson Gilead Sciences Inc Boston Scientific Corp Amgen Inc. Stryker Corp Bristol-Myers Squibb Co Merck & Co., Inc. Eli Lilly & Co Thermo Fisher Scientific Inc. Pfizer Inc. USA Sel Hardy Robert F. Kennedy Jr. Paige Meyers Show more
Finance & Economy, Market Report
20:06 29.11.2024

home health hub market projected to reach over nine billion by 2032

The Home Health Hub Market is projected to grow from USD 0.80 billion in 2023 to USD 9.16 billion by 2032, with a CAGR of 31.29%. Key drivers include the rise of smartphone-based hubs, high-acuity patient monitoring, and increasing demand for remote healthcare solutions, particularly in North America and Asia Pacific. Home care agencies are expected to experience the fastest growth due to the aging population and a shift towards personalized healthcare.
GlobeNewswire News Room
United States Dollar Palantir Technologies Inc. Class A Common Stock Pfizer Inc. Honeywell International Inc. Koninklijke Philips N.V. Cerner CHN USA JPN CAN Show more
Healthcare, Market Report
15:00 27.11.2024

consumer healthcare market poised for rapid growth driven by digital innovations

The consumer healthcare market is projected to grow significantly, reaching $1,476.45 billion by 2028, with a CAGR of 22.1%. Key drivers include an aging population, increased reliance on OTC medications, and the rise of e-commerce. Major players like Johnson & Johnson and Sanofi are adapting to trends in digital health and personalized care solutions.
EIN News
United States Dollar Perrigo Company plc Cardinal Health, Inc. Johnson & Johnson Church & Dwight Co., Inc. Herbalife Nutrition Ltd. Nestlé S.A. Abbott Laboratories Teva Pharmaceutical Industries Ltd. AstraZeneca PLC DSM Nutritional Products AG Pfizer Inc. Colgate-Palmolive Company AbbVie Inc. Bayer AG BASF SE Glaxosmithkline plc Novartis International AG CVS Health Corporation Boehringer Ingelheim International GmbH Sanofi Amway Corporation Novo Nordisk A/S Ipsen S.A. Bristol-Myers Squibb Company McKesson Corporation Merck & Co., Inc. The Clorox Company Reckitt Benckiser Group plc Cigna Corporation Eli Lilly and Company Brian Johnson Show more
Healthcare, Market Report
00:30 27.11.2024

bridgebio receives us approval for heart drug to rival pfizer

BridgeBio Pharma Inc. has received US approval for its heart drug, Attruby, designed to treat transthyretin amyloid cardiomyopathy (ATTR-CM), a serious heart condition. This positions the company to compete directly with Pfizer in a growing market. The drug will be priced at $18,759 for a 28-day supply.
bloomberg.com
United States Dollar BridgeBio Pharma, Inc. Pfizer Inc. USA
Healthcare, News Article
01:34 23.11.2024

Amazon invests 4 billion in Anthropic to enhance AI cloud capabilities

Amazon has doubled its investment in Anthropic to $8 billion, positioning itself as a key player in the AI landscape and establishing AWS as Anthropic's primary cloud partner. This partnership will leverage Amazon's custom-designed chips for AI model training and deployment, enhancing cost-effectiveness and scalability for enterprise customers. As AI adoption accelerates, this strategic move could reshape the competitive dynamics in cloud AI services, potentially positioning Amazon for long-term success against rivals like Microsoft and Google.
VentureBeat
United States Dollar Microsoft Corporation Amazon.com, Inc. Google Inc. Pfizer Inc. USA Show more
Technology & Innovation, Market Report
23:56 22.11.2024

healthcare nanotechnology market poised for rapid growth driven by cancer cases

The healthcare nanotechnology market is projected to grow from $308.03 billion in 2023 to $351.82 billion in 2024, with a CAGR of 14.2%, driven by rising cancer cases and advancements in nanomedicine. By 2028, the market is expected to reach $613.9 billion, fueled by innovations in theranostics and personalized medicine. North America led the market in 2023, highlighting the region's significant role in this expanding field.
openPR.com
United States Dollar Luminex Corporation Sanofi Mallinckrodt plc Abbott Laboratories Teva Pharmaceutical Industries Ltd. Bristol-Myers Squibb Company Pfizer Inc. Merck & Co., Inc. Johnson & Johnson Inc. Celgene Corporation GE HealthCare Technologies Inc. Show more
Healthcare, Market Report
15:59 22.11.2024

rth america oncology drugs market projected to reach 27.20 billion by 2033

The North America oncology drugs market, valued at USD 10.13 billion in 2023, is projected to grow at a CAGR of 10.38%, reaching USD 27.20 billion by 2033. Key drivers include advances in cancer research, rising cancer prevalence, and increasing demand for personalized medicine, while challenges include high drug costs and stringent regulations. The market is segmented into cytotoxic, targeted, and hormonal drugs, with targeted therapies expected to dominate due to their effectiveness and reduced toxicity.
Spherical Insights
United States Dollar Novartis AG Gilead Sciences, Inc. Sanofi Takeda Pharmaceutical Company Limited Johnson & Johnson Amgen Inc. Bristol-Myers Squibb Company Biogen Inc. AstraZeneca PLC Roche Holding AG Pfizer Inc. Merck & Co., Inc. Celgene Corporation AbbVie Inc. Eli Lilly and Company USA Show more
Healthcare, Market Report
14:29 22.11.2024

global pediatric healthcare market poised for significant growth through 2032

The Global Pediatric Healthcare market is projected to grow from $175.6 billion in 2024 to $290 billion by 2032, with a CAGR of 6.5%. Key players include Abbott, Pfizer, and Merck, focusing on pharmaceuticals, nutrition, medical devices, and vaccines across various applications like hospitals and homecare. The market is expanding rapidly in the Asia-Pacific region, while North America remains the dominant market.
openPR.com
Siemens Healthineers AG Pfizer Inc. Medtronic Johnson & Johnson Danone S.A. Philips Merck & Co., Inc. GlaxoSmithKline Nestlé S.A. The Procter & Gamble Company GE HealthCare Technologies Inc. Reckitt Benckiser Group plc Bristol-Myers Squibb Company Sanofi Boston Scientific Corporation Hoffmann-La Roche AG Abbott Novartis AG Bayer USA IND VNM THA IDN SGP MYS JPN KOR HKG AUS PHL TWN CHN Nidhi Bhawsar Show more
Healthcare, Market Report
17:31 20.11.2024

private corner launches healthcare innovation feeder fund for investors

Private Corner has launched the PC Feeder Mérieux Innovation 2, a feeder fund focused on healthcare innovation, categorized as article 8 SFDR. This fund aims to support around 15 European companies in advanced medical technologies, with investments starting at €100,000 over 4 to 5 years. The marketing period will remain open until the end of 2025.
Bourse Direct
Euro Pfizer Inc. FRA JPN Chris Boshoff
Healthcare, Market Report
17:15 20.11.2024
Trending
Subcategory
Corporate News Industry Trends Global Trade Developments Stock Market Updates Startups & Entrepreneurship Industry Mergers & Acquisitions Inflation and Monetary Impact Supply Chain Management Cryptocurrency Trends Government Economic Policies Private Equity Deals CEO Changes Workplace Trends Central Bank Actions Central Banks and Digital Currencies Venture Capital Investments Retail and Consumer Goods Fintech Startups Finance Mergers & Acquisitions Crypto Policies and Governance
Countries:
USA CHN IND JPN TWN ARE SGP SAU MYS EGY IDN THA HKG KOR PHL JOR MUS VNM BHR DEU
Companies:
Apple Inc. Foxconn Technology Co., Ltd. NVIDIA Corporation Nasdaq 100 Jun 25 Tencent Holdings Ltd Google Inc. Nikkei 225 Grab2Go AS Boeing Co Airbus SE Amazon.com, Inc. Oracle AI USD AppLovin Corp. Tesmec S.p.A. DeepSeek R1 USD LG Electronics Inc. Tesla, Inc. MARA Holdings, Inc. Cleanspark Inc Citigroup Inc.
Currencies:
United States Dollar Euro Indian Rupee Chinese Yuan Japanese Yen New Taiwan Dollar Indonesian Rupiah Egyptian Pound Hong Kong Dollar Malaysian Ringgit Filipino Peso West African CFA Franc South Korean Won Saudi Riyal Thai Baht
People:
Donald Trump Jerome Powell Joe Biden Elon Musk George Davis James Smith Torsten Slok Adam Foroughi Karen Kuo Cliff Hou Lai Ching-te Young Liu Augustine Fan Bohan Jiang Tucker Carlson Scott Bessent Sam Abuelsamid Cho Jung-tai Hemal Jain Rinshul Chandra

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Links

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Save settings
Reset settings
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.